Systematic review of the use of translated patient-reported outcome measures in cancer trials

Accepted/In Press date: 8 April 2021

Published date: 26 April 2021

Additional Information: Funding Information: JMB report grants from the National Institute for Health Research and Yorkshire Cancer Research. Funding Information: DK was supported by project funding from Macmillan Cancer Support and reports grants from Innovate UK, the National Institute For Health Research, Birmingham Biomedical Research Centre, and National Institute For Health Research Surgical Reconstruction and Microbiology Research Centre at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust, and personal fees from Merck and GlaxoSmithKline outside the submitted work. Funding Information: This work was supported by funding from the National Institute for Health Research, Clinical Research Network funding (Grant number RHJK20013), and Macmillan Cancer Support (Grant number 5592105). This paper presents independent research supported by the National Institute of Health Research Birmingham Biomedical Research Centre at the University Hospitals Birmingham National Health Service Foundation Trust and the University of Birmingham. The study funders did not have any role in the study design; the collection, analysis, and interpretation of the data; the writing of the report; or the decision to submit the article for publication. Funding Information: GT is funded by the National Institute for Health Research Postdoctoral Fellowship programme (PDF-2017-10-047) and reports funding by the National Institute for Health Research Birmingham Biomedical Research Centre and National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust outside the submitted work. Funding Information: GV reports grants from Pfizer, Breast Cancer NOW, Yorkshire Cancer Research, and European Organisation for Research and Treatment of Cancer and personal fees from Roche, Eisai, and Novartis. Funding Information: AWG reports research grant funding from Macmillan Cancer Support, Prostate Cancer UK, Yorkshire Cancer Research. He is a member of the Teenage and Young Adult Clinical study Group. Funding Information: MC is a National Institute for Health Research Senior Investigator and receives funding from the National Institute for Health Research Birmingham Biomedical Research Centre, the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, and National Institute for Health Research Applied Research Collaboration West Midlands at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust, Health Data Research United Kingdom, Innovate United Kingdom (part of United Kingdom Research and Innovation), Macmillan Cancer Support, Health Foundation, UCB Pharma and GSK. MC has received personal fees from Astellas, Takeda, Merck, Daiichi Sankyo, Glaukos, GlaxoSmithKline, and the Patient-Centred Outcomes Research Institute (PCORI) outside the submitted work. Funding Information: ALS was supported by funding from Macmillan Cancer Support and reports funding by British Heart Foundation, National Institute for Health Research Invention for Innovation, Medical Research Council, National Institute for Health Research MedTech and INvitro diagnostics Co-operative – Trauma management, Eye Hope Foundation, Association du Syndrome de Wolfram, Snow Foundation; Pfizer Health Research Foundation; National Institute for Health Research Clinical Research Network; and National Institute For Health Research Birmingham Biomedical Research Centre and National Institute For Health Research Surgical Reconstruction and Microbiology Research Centre at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust outside the submitted work. Funding Information: AR was supported by funding from Macmillan Cancer Support and reports funding by the National Institute for Health Research Clinical Research Network and Innovate UK (part of UK Research and Innovation) outside the submitted work. Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

Related URLs:

• http://www.scopus.com/inward/r...D=8YFLogxK

Keywords: Patient-reported outcomes (PROs), Patient-reported outcome measures (PROMs), Ethnicity, Recruitment, Cross-cultural translation, Clinical trials, Trial protocols, Primary outcomes, Secondary outcomes

Local EPrints ID: 450811

URI: http://eprints.soton.ac.uk/id/eprint/450811

DOI: doi:10.1186/s13063-021-05255-z

ISSN: 1745-6215

PURE UUID: 6abbabfd-e09a-4765-b184-910d7d34ebcc

ORCID for L. Calman: orcid.org/0000-0002-9964-6017

Date deposited: 12 Aug 2021 16:31

Last modified: 18 Mar 2024 03:20